...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma
04/04/17
> NBE-Therapeutics Expands Board of Directors by the Appointment of Hans-Peter Gerber
04/04/17
> Australia’s Bionic Vision Technologies Raises USD18 Million (AUD23.5 M) to Develop ‘Bionic Eye’ for Global Markets
04/03/17
> Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study
04/03/17
> Calypso Biotech Licenses CALY-001 Best-In-Class Anti-MMP-9 Antibody to EA Pharma
03/31/17
> Vetter’s Dr. Claudia Roth is Appointed to the Fraunhofer Advisory Board
03/28/17
> Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24
03/28/17
> Chemotherapy as a Tablet Instead of an Intravenous Infusion: A Benefit for the Patient
03/27/17
> RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease
03/21/17
> European Group on Tumour Markers (EGTM) Updated Guidelines Recommend Agendia’s MammaPrint® Test with Highest Level 1A Clinical Evidence
03/21/17
> Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia
03/17/17
> Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management
03/17/17
> Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval
03/14/17
> Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017
03/13/17
> German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence
03/08/17
> Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech
03/06/17
> Apollo Therapeutics: Funding of Four Initial Projects and Operational Update
02/22/17
> AmpTec and CMC Pharma Close Consulting Agreement about API-mRNA Production for IND/CTA Use in Early Phase Clinical Studies
02/21/17
> CellGenix Headquarters Expands to Meet the Increasing Demands for GMP Cell Culture Reagents
02/21/17
> Sartorius Enters Into a Corporate Partnership Program with the European Molecular Biology Laboratory (EMBL)
02/17/17
> Polyganics’ “STOP NEUROMA” Study Interim Data Shows Reduction in Pain
02/16/17
> MammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC
02/15/17
> RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis
02/13/17
> OrthoSera Closes Series B Financing Round
02/09/17
> Trod Medical Receives US Patent Allowance for Prostate Focal Therapy Encage™ Device
02/08/17
> Molecular Devices and MIMETAS Present New Turnkey Solution for Organ-On-A-Chip Market
02/06/17
> Rentschler and Leukocare Announce Strategic Alliance And Equity Investment
02/02/17
> Agendia Co-Founder Laura van ’t Veer Wins European Cancer Organization Clinical Research Award
01/30/17
> Vetter Starts Operations in Its Center for Visual Inspection and Logistics
01/25/17
> Sartorius Stedim Biotech Supports Mainstream Adoption of Quality by Design
01/18/17
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 3 of 49